Capability
Service linesIN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING · COURIERS AND EXPRESS DELIVERY SERVICES
Work mix: 100% prime · 0% sub · primary NAICS 334516 / PSC R604 SUPPORT- ADMINISTRATIVE: MAILING/DISTRIBUTION
Where they win
3 agenciesRecompete exposure: High · 6 in 24mo
Polymedco Cancer Diagnostic Products has an estimated $2.2M in contracts returning to market over the next 24 months.
Agency buyer map
3 buyersRecompete exposure
HighPolymedco Cancer Diagnostic Products has an estimated $2.2M in contracts returning to market over the next 24 months. 3 within 6 months ($1.3M).
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Polymedco Cancer Diagnostic Products hold?
Polymedco Cancer Diagnostic Products (UEI JYKKQ1NLJRX7) shows $13.0M across 407 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Polymedco Cancer Diagnostic Products have?
Polymedco Cancer Diagnostic Products shows $13.0M across 407 award actions. SCOUT tracks 6 incumbent recompetes ($2.2M) returning to market in the next 24 months.
Which agencies does Polymedco Cancer Diagnostic Products work with?
Polymedco Cancer Diagnostic Products’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (45%), Department of Defense (DOD) (4%), Department of Health and Human Services (HHS) (1%).
What is the UEI for Polymedco Cancer Diagnostic Products?
The Unique Entity ID (UEI) for Polymedco Cancer Diagnostic Products is JYKKQ1NLJRX7.
Does Polymedco Cancer Diagnostic Products have contracts coming up for recompete?
Yes — SCOUT tracks 6 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.
Ten of these with the durability read on each: the FY27 Sprint Pack, $2,800 through Sept 30.
The Pack is ten Pursuit Analyses in a 12-month balance. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
See Tactics on the pricing pageScout Tactics is $290 a month, with the teaming tools on. It is not sold on this page.
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.